alanine has been researched along with (S)-nadifloxacin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, A; Chugh, R; Gotfried, MH; Gupta, M; Patel, A; Rodvold, KA; Yeole, R | 1 |
| Ahirrao, VK; Patil, KR; Rane, VP; Yeole, RD | 1 |
| Ahirrao, V; Jadhav, R; More, K; Patil, K; Rane, V; Yeole, R | 1 |
| Bhagwat, S; Bhawsar, S; Deshpande, P; Kale, R; Patel, M; Yeole, R | 1 |
1 trial(s) available for alanine and (S)-nadifloxacin
| Article | Year |
|---|---|
Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
Topics: Administration, Oral; Adolescent; Adult; Alanine; Anti-Bacterial Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Chromatography, Liquid; Drug Administration Schedule; Drug Dosage Calculations; Female; Fluoroquinolones; Half-Life; Humans; Lung; Macrophages, Alveolar; Male; Middle Aged; Prodrugs; Respiratory Mucosa; Tandem Mass Spectrometry | 2018 |
3 other study(ies) available for alanine and (S)-nadifloxacin
| Article | Year |
|---|---|
Impurity Profiling of a Novel Anti-MRSA Antibacterial Drug: Alalevonadifloxacin.
Topics: Alanine; Anti-Bacterial Agents; Chromatography, Reverse-Phase; Drug Contamination; Fluoroquinolones; Limit of Detection; Linear Models; Mass Spectrometry; Reproducibility of Results | 2020 |
Reverse-phase chiral high-performance liquid chromatography for separation of a diastereomer in alalevonadifloxacin: A novel antibacterial agent.
Topics: Alanine; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Contamination; Fluoroquinolones; Limit of Detection; Stereoisomerism | 2021 |
Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection.
Topics: Alanine; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Fluoroquinolones; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Staphylococcal Infections; Structure-Activity Relationship | 2021 |